Diagnostic Performance of Ultrasound Versus Computed Tomography in Evaluating Renal Masses in a Tertiary Care Setting: A Comparative Study
Background: Renal masses encompass a wide spectrum of benign and malignant lesions, necessitating accurate imaging for early detection and appropriate clinical management. Ultrasound (USG) is the initial imaging modality for renal mass detection due to its accessibility and cost-effectiveness, while computed tomography (CT) is widely used for further characterization and staging. This study aims to compare the diagnostic accuracy of ultrasound and CT in differentiating benign and malignant renal masses in a tertiary care setting. Methods: This prospective, hospital-based study was conducted over a period of one year, from January to December 2021, at a tertiary care hospital in south India. A total of 150 patients with clinically suspected or incidentally detected renal masses underwent detailed ultrasound evaluation, followed by contrast-enhanced CT (CECT) for further characterization. Imaging findings were compared based on lesion size, echotexture, enhancement characteristics, and vascular involvement. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of ultrasound were calculated using CT as the reference standard. Results: Among the 150 renal masses, 96 cases (64%) were malignant, while 54 cases (36%) were benign. The most common malignant lesion was renal cell carcinoma (RCC) in 78.1% of malignant cases, followed by urothelial carcinoma (12.5%) and Wilms tumor (9.4%). Among benign lesions, simple renal cysts (51.8%) and angiomyolipomas (31.4%) were the most frequently observed. Ultrasound demonstrated an overall sensitivity of 85.4% and specificity of 89.1% in differentiating benign from malignant renal masses. The sensitivity was highest for detecting simple cysts and solid exophytic tumors but was lower for complex cystic masses, where CT provided better delineation of septations, calcifications, and contrast enhancement patterns. CT was particularly useful in identifying vascular invasion and extracapsular extension, which were often inconclusive on ultrasound. The correlation between ultrasound and CT findings was statistically significant (p < 0.001). Conclusion: Ultrasound is an effective first-line imaging tool for detecting renal masses, with high sensitivity and specificity in differentiating solid from cystic lesions. However, CT remains the gold standard for detailed characterization, staging, and vascular assessment. The findings support a stepwise imaging approach, where ultrasound serves as an initial screening tool, with CT reserved for further evaluation of indeterminate or complex renal masses.